1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Recurrent Glioma: new trials by email Literature Review of Recurrent Glioma trials Research Report on Recurrent Glioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PARP Inhibition for Gliomas (PI-4G or π4g) Niraparib - Recurrent Glioblastoma, Recurrent Astrocytoma | Phase 2 | Terminated | University of Oklahoma | 15 | 2022-06-09 | 2025-05-23 |
Astrocytoma (1) · Glioblastoma (1) · Glioma (1) · Oligodendroglioma (1)
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Neuroectodermal Tumors (1)
niraparib (1)
United States (1)